Authors: HUNG MC CHANG JYJ XING XM

Citation: Mc. Hung et al., PRECLINICAL AND CLINICAL-STUDY OF HER-2 NEU-TARGETING CANCER GENE-THERAPY/, Advanced drug delivery reviews, 30(1-3), 1998, pp. 219-227

Authors: MILLER SJ XING XM XI L HUNG MC

Citation: Sj. Miller et al., IDENTIFICATION OF A SPECIFIC DNA REGION REQUIRED FOR ENHANCED TRANSCRIPTION OF HER2 NEU IN THE MDA-MB453 BREAST-CANCER CELL-LINE/, DNA and cell biology, 15(9), 1996, pp. 749-757

Authors: XING XM MATIN A YU DH XIA WY SORGI F HUANG L HUNG MC

Citation: Xm. Xing et al., MUTANT SV40 LARGE T-ANTIGEN AS A THERAPEUTIC AGENT FOR HER-2 NEU-OVEREXPRESSING OVARIAN-CANCER/, Cancer gene therapy, 3(3), 1996, pp. 168-174

Authors: HUNG MC MATIN A ZHANG YJ XING XM SORGI F HUANG L YU DH

Citation: Mc. Hung et al., HER-2 NEU-TARGETING GENE-THERAPY - A REVIEW, Gene, 159(1), 1995, pp. 65-71